Duration of Protection and Humoral Immune Response in Nile Tilapia (Oreochromis niloticus L.) Vaccinated against Streptococcus agalactiae.

Streptococcosis caused by Streptococcus agalactiae (S. agalactiae) is a major bacterial disease affecting the production of Nile tilapia (Oreochromis niloticus L.), causing significant economic losses due to mortality in the growing phase. Vaccination is the most effective method for preventing streptococcosis on Nile tilapia farms. In Brazil, the major tilapia-producing regions have long production cycles (6-10 months) and harvest tilapias weighing over 900 g for fillet production. Thus, data on the duration of the humoral immune response and protection in farmed tilapia have not been reported or are poorly described. Furthermore, the efficiency of serological testing for the long-term monitoring of immune responses induced by vaccination against S. agalactiae has never been addressed. This study evaluated the duration of protection and humoral immune response induced in Nile tilapia vaccinated against S. agalactiae until 300 days post-vaccination (dpv). The immunization trial was composed of two groups: vaccinated (Vac), vaccinated intraperitoneally with a commercial vaccine, and unvaccinated (NonVac) group, injected fish with sterile saline solution. At 15, 30, 150, 180, 210, and 300 dpv, blood sampling was conducted to detect anti-S. agalactiae IgM antibodies using indirect Enzyme-Linked Immunosorbent Assay (ELISA), and the fish were challenged with pathogenic S. agalactiae to determine the duration of vaccine protection through relative percentage survival (RPS). Spearman's rank correlation was performed between the ELISA optical density (OD) of vaccinated tilapia and the duration of vaccine protection (RPS). The mean cumulative mortality in NonVac and Vac groups ranged from 65 to 90% and less than 35%, respectively. The average RPS was 71, 93, 94, 70, 86, and 67% at 15, 30, 150, 180, 210, and 300 dpv, respectively. RPS revealed that the vaccine provided protection from 15 to 300 dpv. The specific anti-S. agalactiae IgM antibody levels were significantly higher in the Vac group than that non-Vac group up to 180 dpv. The vaccinated fish exhibited significant protection for up to 10 months after vaccination. There was a positive correlation between the antibody response and RPS. This study revealed that a single dose of commercial vaccine administered to Nile tilapia can confer long-term protection against S. agalactiae and that indirect ELISA can monitor the duration of the humoral immune response for up to six months following vaccination. Finally, vaccine protection over six months can be associated with other components of the fish immune system beyond the humoral immune response by IgM antibodies.

Susceptibility Profile and Epidemiological Cut-Off Values Are Influenced by Serotype in Fish Pathogenic Streptococcus agalactiae.

Streptococcus agalactiae is a major health concern in tilapia farming worldwide. In contrast to the availability of susceptibility profile results, interpretative criteria for disk diffusion assays and the influence of serotypes on resistance profiles are not available. To address this, sixty isolates (thirty of each serotype, Ib and III) were evaluated using the disk diffusion assay against six antibiotics, and the epidemiological cut-off value (ECV) was calculated. All the isolates were classified as non-wild type (NWT) for sulfamethoxazole (SUT) and norfloxacin (NOR). The inhibition zones for oxytetracycline (OXY) and doxycycline (DOX) were largely distinct; all serotype Ib and III isolates were classified as wild-type (WT) and NWT, respectively. The results for serotype III of fish group B Streptococcus (GBS) were comparable to the NWT tetracycline profile of human GBS available in EUCAST, suggesting the presence of resistance mechanisms in these fish isolates. The calculation of the cut-off wild type (COWT) values for OXY and DOX was appropriate for both serotypes. Differences between the distribution of florfenicol (FLO) and amoxicillin (AMO) were found, and we attribute this to the faster growth rate of serotype III, which promotes smaller inhibition zones. Therefore, using separate COWT for each serotype is necessary. In conclusion, the serotype of fish GBS affects its susceptibility profile, and it is recommended to use serotype-specific COWT values as interpretative criteria for disk diffusion assays against FLO and AMO.

Main Causes of Death in Piglets from Different Brazilian Nursery Farms Based on Clinical, Microbiological, and Pathological Aspects.

Necropsies can reveal herd problems or comorbidities that can lead to management corrections, improvements in animal performance, and better decision making. Furthermore, the pattern and causes of mortality might differ when different systems are evaluated. The present study was conducted to establish the main causes of death in nursery pigs from different systems in Brazil, as well as the clinical, microbiological, and pathological aspects of these mortalities. Eighteen nurseries were analyzed (a total of 120,243 housed piglets), and 557 necropsies were performed. Streptococcus suis infection was the most prevalent cause of death (21.2%), followed by bacterial polyserositis (16.7%), chronic atrophic enteritis (13.5%), salmonellosis (8.8%), pneumonia (8.6%), and colibacillosis (6.1%). The increase in mortality rate in individual nurseries and, consequently, in the diagnoses was commonly associated with disease outbreaks. Infectious diseases constituted the largest portion of the diagnoses, making a great opportunity for improving production rates in herds. Moreover, the extensive range of observed diagnoses highlights the importance of conducting preliminary diagnostic investigations based on necropsy to determine the causes of death. This approach allows for the direction of complementary tests, which can diagnose agents with greater specificity. As a result, this allows for the implementation of more effective prevention and control strategies.

Análise de ângulos e pontos para vacinação de tilápias-do-nilo / Analysis of angles and points for nile tilapia vaccination / Análisis de ángulos y puntos para la vacunación la tilapia del nilo

Objetivou-se com o presente estudo avaliar diferentes ângulos e pontos de vacinação de juvenis de Tilapias-do-Nilo contra streptococose. Foram vacinados 450 juvenis de tilápias-do-nilo (Oreochroimis niloticus). Os animais foram divididos em três grupos (n=150) de acordo com seus pesos (grupo um: 140 g; grupo dois: 225 g e grupo três: 295 g). Os peixes foram vacinados em diferentes ângulos (45° ou 90°) e em diferentes pontos localizados na região intraperitoneal, entre as nadadeiras pélvicas (Ponto 0- meia nadadeira; ponto 1- entre meia nadadeira e a inserção da nadadeira, ponto 2 ­ paralelo a inserção da nadadeira), totalizando 75 peixes para cada ângulo proposto e 25 peixes para cada ponto de vacinação. Utilizou-se vacina comercial inativada com adjuvante oleoso contra Streptococcus agalactiae. Para análise do manejo vacinal elaborou-se um formulário que foi preenchido dividindo os peixes como bem vacinados, pouco vacinados e sem vacina. Os resultados foram obtidos por análise visual e expressos em porcentagem de acordo com os critérios estabelecidos. A vacinação do grupo um (140 g) e do grupo dois (225 g) no ângulo de 90° no ponto 2 possibilitou que 88% dos peixes fossem bem vacinados. O grupo três (295g) também foi melhor vacinado no ângulo de 90° no ponto 2, com 80% dos peixes bem vacinados. O ângulo de 90° no ponto 2 se mostrou mais eficiente para vacinação de juvenis de tilápia-do-Nilo para ambos os grupos de peso estudados.(AU)

The objective of this study was to evaluate different angles and points of vaccination of juvenile Nile Tilapia against streptococcosis. 450 juveniles of Nile tilapia (Oreochromis niloticus) were vaccinated. The animals were divided into three groups (n = 150) according to their weight (group one: 140 g; group two: 225 g and group three: 295 g). The fish were vaccinated at different angles (45 ° or 90 °) and at different points located in the intraperitoneal region, between the pelvic fins (Point 0- half fin; point 1- between half fin and the insertion of the fin, point 2 - parallel inserting the fin), totaling 75 fish for each proposed angle and 25 fish for each vaccination point. Inactivated commercial vaccine with oily adjuvant against Streptococcus agalactiae was used. For the analysis of vaccine management, a form was elaborated that was filled out dividing the fish as well vaccinated, poorly vaccinated and without vaccine. The results were obtained by visual analysis and expressed as a percentage according to the established criteria. The vaccination of group one (140 g) and group two (225 g) at the 90 ° angle at point 2 allowed 88% of the fish to be well vaccinated. Group three (295g) was also better vaccinated at the 90 ° angle at point 2, with 80% of the fish well vaccinated. The 90 ° angle at point 2 was more efficient for vaccinating juvenile Nile tilapia for both weight groups studied.(AU)

El objetivo de este estudio fue evaluar diferentes ángulos y puntos de vacunación de juvenilesde Tilapia del Nilo contra estreptococosis. Se vacunaron 450 juveniles de tilapia del Nilo(Oreochromis niloticus). Los animales se dividieron en tres grupos (n = 150) según supeso(grupo uno: 140 g; grupo dos: 225 gy grupo tres: 295 g). Los peces fueron vacunados endiferentes ángulos (45 ° y 90 °) y en diferentes puntos ubicados en la región intraperitoneal, entre las aletas pélvicas (Punto 0- media aleta; punto 1- entre média aleta y la insercióndelaaleta, punto 2 - paralelo insertando la aleta), totalizando 75 peces por cada ángulo propuestoy 25 peces por cada punto de vacunación. Se utilizó vacuna comercial inactivada conadyuvante oleoso contra Streptococcus agalactiae. Para el análisis del manejo de vacunas seelaboró un formulario que se llenó dividiendo a los peces bien vacunados, mal vacunadosysin vacuna. Los resultados se obtuvieron mediante análisis visual y se expresaronenporcentaje según los criterios establecidos. La vacunación del grupo uno (140 g) y del grupodos (225 g) en el ángulo de 90 ° en el punto 2 permitió que el 88% de los peces estuvieranbien vacunados. El grupo tres (295 g) también se vacunó mejor en el ángulo de 90 ° enel punto 2, con el 80% de los peces bien vacunados. El ángulo de 90 ° en el punto 2 fue máseficiente para vacunar a la tilapia juvenil del Nilo para ambos os grupos de peso estudados.(AU)

Testing Novel Inactivation Methods and Adjuvants for Vaccines Against Streptococcus agalactiae in Nile Tilapia Oreochromis niloticus.

Inactivation by hydrogen peroxide and pH manipulation are two novel methods used recently in experimental vaccines against Streptococcus agalactiae in Nile tilapia. Here we describe in detail inactivation using novel methods as well as the classical method of inactivation. These vaccines showed similar moderate efficacy when compared to the conventional formaldehyde vaccine. In addition, we describe the inclusion of adjuvants in a hydrogen peroxide vaccine.

Thymomodulin enhances vaccination responses against Streptococcus agalactiae in Nile tilapia / Timomodulina melhora as respostas vacinais contra Streptococcus agalactiae em tilápia-do-Nilo

Streptococcosis caused by Streptococcus agalactiae is a major economic problem for Nile tilapia Oreochromis niloticus production worldwide. Inactivated vaccines are considered an efficient method for controlling streptococcosis. However, during the vaccination process, stress during fish handling could affect the immune response. Immunomodulators, such as thymomodulin, act on the immune system and can improve vaccination responses. Thus, the aim of this study was to assess the immunomodulatory effect of thymomodulin in O. niloticus vaccinated against S. agalactiae. For this, fish were distributed in a factorial design (2x2x6), corresponding to two levels of thymomodulin supplementation (0.0 and 0.3%), two treatments (sterile phosphate buffered saline and inactivated S. agalactiae vaccine). Initially, fish received thymomodulin supplementation for 30 days. Next, fish were vaccinated by injection intraperitoneal (i.p.) of heat inactivated S. agalactiae vaccine. 15 days after vaccination, all fish were challenged i.p. with S. agalactiae and blood samples were collected at 7, 14, 21 days post infection (DPI). Results revealed that fish supplemented with thymomodulin vaccinated or not developed better protection against S. agalactiae than vaccinated fish without thymomodulin. Furthermore, fish vaccinated and supplemented with thymomodulin presented high levels of antibodies after 14

A estreptococose causada pelo Streptococcus agalactiae é um grande problema econômico para a produção de tilápia-do-nilo Oreochromis niloticus em todo o mundo. As vacinas inativadas são consideradas um método eficiente para o controle da estreptococose. No entanto, durante o processo de vacinação o estresse durante o manejo dos peixes pode afetar sua resposta imune. Imunomoduladores como a timomodulina, atuam no sistema imunológico e podem melhorar as respostas vacinais. Assim, o objetivo deste estudo foi avaliar o efeito imunomodulador da timomodulina em O. niloticus vacinado contra S. agalactiae. Para isso, os peixes foram distribuídos em esquema fatorial (2x2x6), correspondendo a dois níveis de suplementação de timodulina (0,0 e 0,3%), dois tratamentos (solução salina tamponada com fosfato estéril e vacina S. agalactiae inativada). Inicialmente, os peixes receberam suplementação de timomodulina por 30 dias. Em seguida, os peixes foram vacinados por via intraperitoneal (i.p.) da vacina de S. agalactiae inativada pelo calor. 15 dias após a vacinação, todos os peixes foram desafiados i.p. com S. agalactiae e amostras de sangue foram coletadas aos 7, 14, 21 dias após a infecção (DPI). Os resultados revelaram que os peixes suplementados com timomodulina vacinados ou não desenvolveram melhor proteção contra S. agalactiae do que os peixes vacinados sem timomodulina. Além disso, os

Thymomodulin enhances vaccination responses against Streptococcus agalactiae in Nile tilapia / Timomodulina melhora as respostas vacinais contra Streptococcus agalactiae em tilápia-do-Nilo

Streptococcosis caused by Streptococcus agalactiae is a major economic problem for Nile tilapia Oreochromis niloticus production worldwide. Inactivated vaccines are considered an efficient method for controlling streptococcosis. However, during the vaccination process, stress during fish handling could affect the immune response. Immunomodulators, such as thymomodulin, act on the immune system and can improve vaccination responses. Thus, the aim of this study was to assess the immunomodulatory effect of thymomodulin in O. niloticus vaccinated against S. agalactiae. For this, fish were distributed in a factorial design (2x2x6), corresponding to two levels of thymomodulin supplementation (0.0 and 0.3%), two treatments (sterile phosphate buffered saline and inactivated S. agalactiae vaccine). Initially, fish received thymomodulin supplementation for 30 days. Next, fish were vaccinated by injection intraperitoneal (i.p.) of heat inactivated S. agalactiae vaccine. 15 days after vaccination, all fish were challenged i.p. with S. agalactiae and blood samples were collected at 7, 14, 21 days post infection (DPI).Results revealed that fish supplemented with thymomodulin vaccinated or not developed better protection against S. agalactiae than vaccinated fish without thymomodulin. Furthermore, fish vaccinated and supplemented with thymomodulin presented high levels of antibodies after 14 and21 DPI, suggesting that thymomodulin can promote the immune response in Nile tilapia.

A estreptococose causada pelo Streptococcus agalactiae é um grande problema econômico para a produção de tilápia-do-nilo Oreochromis niloticus em todo o mundo. As vacinas inativadas são consideradas um método eficiente para o controle da estreptococose. No entanto, durante o processo de vacinação o estresse durante o manejo dos peixes pode afetar sua resposta imune. Imunomoduladores como a timomodulina, atuam no sistema imunológico e podem melhorar as respostas vacinais. Assim, o objetivo deste estudo foi avaliar o efeito imunomodulador da timomodulina em O. niloticus vacinado contra S. agalactiae. Para isso, os peixes foram distribuídos em esquema fatorial (2x2x6), correspondendo a dois níveis de suplementação de timodulina (0,0 e 0,3%), dois tratamentos (solução salina tamponada com fosfato estéril e vacina S. agalactiae inativada). Inicialmente, os peixes receberam suplementação de timomodulina por 30 dias. Em seguida, os peixes foram vacinados por via intraperitoneal (i.p.) da vacina de S. agalactiae inativada pelo calor. 15 dias após a vacinação, todos os peixes foram desafiados i.p. com S. agalactiae e amostras de sangue foram coletadas aos 7, 14, 21 dias após a infecção (DPI). Os resultados revelaram que os peixes suplementados com timomodulina vacinados ou não desenvolveram melhor proteção contra S. agalactiae do que os peixes vacinados sem timomodulina. Além disso, os peixes vacinados e suplementados com timomodulina apresentaram altos níveis de anticorpos após 14 e 21 DPI, sugerindo que a timomodulina pode promover a resposta imune em tilápia-do-nilo.

Meningitis Caused by Streptococcus agalactiae in Nile Tilapia (Oreochromis niloticus): Infection and Inflammatory Response.

Streptococcus agalactiae (Sta) of Lancefield group B is the primary etiological agent of bacterial meningitis in Nile tilapia and newborn humans. Thus, the study of this disease is of fundamental importance for aquaculture and human medicine. Additionally, elucidation of the mechanisms involved in the host-pathogenic response is important for the success of new therapies. In the present study, we elucidated important aspects of the innate immune response in the brain tissue of Nile tilapia (Oreochromis niloticus) infected by Sta. The neuroinflammatory process in the meninges started with the migration of MHC class II and CD68 + cells, production of TNF-alpha, and the effective immune response to Sta was mediated by the increased iNOs+. In conclusion, the present study brings a partial understanding of the pathophysiological and neuroinflammatory mechanisms in meningitis in Sta infected tilapia, enabling important advances in the therapy of this disease as well as the possibility of using this biological model to understand human meningitis.

In silico Prediction of New Drug Candidates Against the Multidrug-Resistant and Potentially Zoonotic Fish Pathogen Serotype III Streptococcus agalactiae.

Streptococcus agalactiae is an invasive multi-host pathogen that causes invasive diseases mainly in newborns, elderly, and individuals with underlying health complications. In fish, S. agalactiae causes streptococcosis, which is characterized by septicemia and neurological signs, and leads to great economic losses to the fish farming industry worldwide. These bacteria can be classified into different serotypes based on capsular antigens, and into different sequence types (ST) based on multilocus sequence typing (MLST). In 2015, serotype III ST283 was identified to be associated with a foodborne invasive disease in non-pregnant immunocompetent humans in Singapore, and the infection was related to raw fish consumption. In addition, a serotype III strain isolated from tilapia in Brazil has been reported to be resistant to five antibiotic classes. This specific serotype can serve as a reservoir of resistance genes and pose a serious threat to public health. Thus, new approaches for the control and treatment of S. agalactiae infections are needed. In the present study, 24 S. agalactiae serotype III complete genomes, isolated from human and fish hosts, were compared. The core genome was identified, and, using bioinformatics tools and subtractive criteria, five proteins were identified as potential drug targets. Furthermore, 5,008 drug-like natural compounds were virtually screened against the identified targets. The ligands with the best binding properties are suggested for further in vitro and in vivo analysis.

Multilocus sequence analysis of diverse Streptococcus iniae isolates indicates an underlying genetic basis for phenotypic heterogeneity.

Streptococcus iniae is a Gram-positive, opportunistically zoonotic bacterium infective to a wide variety of farmed and wild fish species worldwide. Outbreaks in wild fish can have detrimental environmental and cultural impacts, and mortality events in aquaculture can result in significant economic losses. As an emerging or re-emerging pathogen of global significance, understanding the coalescing factors contributing to piscine streptococcosis is crucial for developing strategies to control infections. Intraspecific antigenic and genetic variability of S. iniae has made development of autogenous vaccines a challenge, particularly where the diversity of locally endemic S. iniae strains is unknown. This study genetically and phenotypically characterized 11 S. iniae isolates from diseased wild and farmed fish from North America, Central America, and the Caribbean. A multilocus sequence analysis (MLSA) scheme was developed to phylogenetically compare these isolates to 84 other strains of Streptococcus spp. relevant to aquaculture. MLSA generated phylogenies comparable to established genotyping methods, and isolates formed distinct clades related to phenotype and host species. The endothelial Oreochromis mossambicus bulbus arteriosus cell line and whole blood from rainbow trout Oncorhynchus mykiss, Nile tilapia Oreochromis niloticus, and white sturgeon Acipenser transmontanus were used to investigate the persistence and virulence of the 11 isolates using in vitro assays. In vivo challenges using an O. niloticus model were used to evaluate virulence by the intragastric route of infection. Isolates showed significant differences (p < 0.05) in virulence and persistence, with some correlation to genogroup, establishing a basis for further work uncovering genetic factors leading to increased pathogenicity.

Evaluation of resistance against Streptococcus agalactiae in four farmed strains of Nile tilapia (Oreochromis niloticus) / Avaliação da resistência contra Streptococcus agalactiae em quatro linhagens cultivadas de tilápia do Nilo (Oreochromis niloticus)

Nile tilapia (Oreochromis niloticus) has always been considered more resistant to diseases compared to other fish species. However, in recent decades, this fish species has also been susceptible to many bacterial, fungal, parasitic, and nutritional diseases. In Brazil, streptococcosis is one of the main diseases that affect tilapia and has caused many economic losses. A resistance test was conducted with 93 tilapia of four varieties (UFLA strain and three commercial varieties: SC1, SC2, and SC3) to evaluate resistance to experimental inoculation with Streptococcus agalactiae. Each variety was distributed in five aquariums, with nine specimens of the same variety. Among the five aquariums, four housed fish were intraperitoneally inoculated with 10(7) CFU/fish of S. agalactiae and one aquarium harbored fish from the control group, which received 0.1 mL of sterile BHI (Brain Heart Infusion). Significant differences were observed in the survival rates accumulated at the end of the experiment (day 15), with values of 22, 36, 36, and 15% for SC1, SC2, SC3, and UFLA, respectively. The UFLA strain presented lower survival than other strains, which did not differ among the 15 days of challenge. These results demonstrate that there are animals with a better response to the resistance test than others.

A tilápia do Nilo (Oreochromis niloticus) sempre foi considerada mais resistente a doenças em comparação com outras espécies de peixes, porém, nas últimas décadas, essa espécie de peixe também foi suscetível a muitas doenças bacterianas, fúngicas, parasitárias e nutricionais. No Brasil, a estreptococose é uma das principais doenças que afetam a tilápia e causou muitas perdas econômicas. Um teste de resistência foi realizado com 93 tilápias de quatro variedades (linhagem UFLA e três variedades comerciais: SC1, SC2 e SC3) para avaliar a resistência à inoculação experimental com Streptococcus agalactiae. Cada variedade foi distribuída em cinco aquários, com nove espécimes da mesma variedade. Entre os cinco aquários, quatro peixes abrigados foram inoculados intraperitonealmente com 10(7) UFC / peixe de S. agalactiae e um aquário abrigou peixes do grupo controle, que receberam 0,1 mL de BHI estéril (infusão cardíaca cerebral). Diferenças significativas foram observadas nas taxas de sobrevivência acumuladas no final do experimento (dia 15), com valores de 22, 36, 36 e 15% para SC1, SC2, SC3 e UFLA, respectivamente. A linhagem UFLA apresentou menor sobrevivência que as demais, o que não diferiu entre os 15 dias de desafio. Esses resultados demonstram que existem animais com melhor resposta ao teste de resistência do que outros.

Evaluation of resistance against Streptococcus agalactiae in four farmed strains of Nile tilapia (Oreochromis niloticus) / Avaliação da resistência contra Streptococcus agalactiae em quatro linhagens cultivadas de tilápia do Nilo (Oreochromis niloticus)

Nile tilapia (Oreochromis niloticus) has always been considered more resistant to diseases compared to other fish species. However, in recent decades, this fish species has also been susceptible to many bacterial, fungal, parasitic, and nutritional diseases. In Brazil, streptococcosis is one of the main diseases that affect tilapia and has caused many economic losses. A resistance test was conducted with 93 tilapia of four varieties (UFLA strain and three commercial varieties: SC1, SC2, and SC3) to evaluate resistance to experimental inoculation with Streptococcus agalactiae. Each variety was distributed in five aquariums, with nine specimens of the same variety. Among the five aquariums, four housed fish were intraperitoneally inoculated with 10(7) CFU/fish of S. agalactiae and one aquarium harbored fish from the control group, which received 0.1 mL of sterile BHI (Brain Heart Infusion). Significant differences were observed in the survival rates accumulated at the end of the experiment (day 15), with values of 22, 36, 36, and 15% for SC1, SC2, SC3, and UFLA, respectively. The UFLA strain presented lower survival than other strains, which did not differ among the 15 days of challenge. These results demonstrate that there are animals with a better response to the resistance test than others.(AU)

A tilápia do Nilo (Oreochromis niloticus) sempre foi considerada mais resistente a doenças em comparação com outras espécies de peixes, porém, nas últimas décadas, essa espécie de peixe também foi suscetível a muitas doenças bacterianas, fúngicas, parasitárias e nutricionais. No Brasil, a estreptococose é uma das principais doenças que afetam a tilápia e causou muitas perdas econômicas. Um teste de resistência foi realizado com 93 tilápias de quatro variedades (linhagem UFLA e três variedades comerciais: SC1, SC2 e SC3) para avaliar a resistência à inoculação experimental com Streptococcus agalactiae. Cada variedade foi distribuída em cinco aquários, com nove espécimes da mesma variedade. Entre os cinco aquários, quatro peixes abrigados foram inoculados intraperitonealmente com 10(7) UFC / peixe de S. agalactiae e um aquário abrigou peixes do grupo controle, que receberam 0,1 mL de BHI estéril (infusão cardíaca cerebral). Diferenças significativas foram observadas nas taxas de sobrevivência acumuladas no final do experimento (dia 15), com valores de 22, 36, 36 e 15% para SC1, SC2, SC3 e UFLA, respectivamente. A linhagem UFLA apresentou menor sobrevivência que as demais, o que não diferiu entre os 15 dias de desafio. Esses resultados demonstram que existem animais com melhor resposta ao teste de resistência do que outros.(AU)

Can histology and haematology explain inapparent Streptococcus agalactiae infections and asymptomatic mortalities on Nile tilapia farms?

The aim of this study was to characterise possible histopathological and haemato-immunological changes after subclinical infection by S. agalactiae S13 serotype Ib. One hundred juveniles of Nile tilapia with average weight of 45 g were distributed in ten 90 L experimental units. After the acclimation period 25 fish were euthanised, and fragments of liver, spleen and posterior mid-intestine tissue were sampled to verify the integrity of the organs and blood samples taken to check the haematological profile. Fifty animals were used to verify the optimal dosage for the challenge. The remaining 25 fish were infected with S. agalactiae S13. After 96 h, tissue fragments from the liver, spleen and posterior mid-intestine and blood samples were collected. The analyses revealed that, 96 h after contagion, S. agalactiae S13 serotype Ib caused subclinical lesions in the liver and spleen that are not commonly described as pathognomonic, in addition to haematological alterations. These results allow a better understanding of sudden recurrent mortalities in Brazilian tilapia farms, since the serotype Ib of S. agalactiae causes inapparent infections and can remain lodged in internal organs and cause irreversible lesions and haemato-immunological alterations, therefore compromising physiological functions vital for the health of fish without revealing external clinical signs in the animals.

Meningitis caused by Streptococcus agalactiae in nile tilapia (Oreochromis niloticus): infection and inflammatory response

Streptococcus agalactiae (Sta) of Lancefield group B is the primary etiological agent of bacterial meningitis in Nile tilapia and newborn humans. Thus, the study of this disease is of fundamental importance for aquaculture and human medicine. Additionally, elucidation of the mechanisms involved in the host–pathogenic response is important for the success of new therapies. In the present study, we elucidated important aspects of the innate immune response in the brain tissue of Nile tilapia (Oreochromis niloticus) infected by Sta. The neuroinflammatory process in the meninges started with the migration of MHC class II and CD68 + cells, production of TNF-alpha, and the effective immune response to Sta was mediated by the increased iNOs+. In conclusion, the present study brings a partial understanding of the pathophysiological and neuroinflammatory mechanisms in meningitis in Sta infected tilapia, enabling important advances in the therapy of this disease as well as the possibility of using this biological model to understand human meningitis.

Omphalitis, urachocystitis and septicemia by Streptococcus dysgalactiae in a southern right whale calf Eubalaena australis, Brazil.

Southern right whales Eubalaena australis (SRW) use the southern coast of Brazil as a wintering and calving ground. Other than anthropogenic threats, there is limited knowledge on health and disease aspects for this species. We report the gross and microscopic findings and microbiological identification of streptococcal septicemia in a SRW calf. Main gross findings included fibrinosuppurative omphalitis and urachocystitis, suppurative cystitis, valvular endocarditis and myocarditis, embolic pneumonia, suppurative myositis and osteoarthritis, and lymphadenomegaly. Histological examination confirmed the above inflammatory processes and indicated disseminated Gram-positive coccoid septicemia. PCR analysis, based on the 16S rRNA gene from bacteria isolated on blood agar, identified Streptococcus dysgalactiae. Pathologic and microbiologic analysis indicated that ß-hemolytic S. dysgalactiae septicemia, presumably initiated as ascending omphalic infection, was responsible for stranding and death in this individual. These results further confirm pathogenicity of streptococci in cetaceans and add to the limited health and disease related pathology knowledge for this species.

Involvement of xanthine oxidase activity with oxidative and inflammatory renal damage in silver catfish experimentally infected with Streptococcus agalactiae: Interplay with reactive oxygen species and nitric oxide.

Xanthine oxidase (XO) is a final enzyme of purine metabolism linked with initiation and progression of infectious diseases, since is considered an important source of reactive oxygen species (ROS) and nitric oxide (NO), developing a pro-oxidant and pro-inflammatory profile in some infectious diseases. Thus, the aim of this study was to evaluate the involvement of XO activity in the renal oxidative and inflammatory damage, as well as the interplay with ROS and metabolites of nitric oxide (NOx) levels in silver catfish experimentally infected with Streptococcus agalactiae. Xanthine oxidase activity, and uric acid, ROS and NOx levels increased in renal tissue of infected animals compared to uninfected animals. Moreover, the histopathological analyses revealed the presence of necrosis, generalized edema and nuclear degeneration of renal tubules. Based on these evidences, the upregulation on renal XO activity exerts a pro-oxidant and pro-inflammatory profile in kidney of fish infected with S. agalactiae. The excessive uric acid levels induced the release of oxidative and inflammatory mediators, such as ROS and NOx, that directly contribute to renal oxidative and inflammatory damage. In summary, the upregulation on XO activity may be considered a pathway involved in the renal injury during S. agalactiae infection.

Natural coinfection by Streptococcus agalactiae and Francisella noatunensis subsp. orientalis in farmed Nile tilapia (Oreochromis niloticus L.).

Streptococcus agalactiae and Francisella noatunensis subsp. orientalis (Fno) are important pathogens for farm-raised tilapia worldwide. There are no reports of coinfection caused by S. agalactiae and Fno in fish. This study aimed to determine the aetiology of atypical mortalities in a cage farm of Nile tilapia and to characterize the genetic diversity of the isolates. Fifty-two fish were sampled and subjected to parasitological and bacteriological examination. The S. agalactiae and Fno isolates were genotyped using MLST and REP-PCR, respectively. Whole-genome sequencing was performed to confirm the MLST results. Seven fish were shown coinfected by S. agalactiae and Fno. Chronic hypoxia and a reduction in the water temperature were determined as risk factors for coinfection. Fno isolates were shown clonally related in REP-PCR. The MLST analysis revealed that the S. agalactiae isolates from seven coinfected fish were negative for the glcK gene; however, these were determined to be members of clonal complex CC-552. This is the first description of coinfection by S. agalactiae and Fno in farm-raised Nile tilapia. The coinfection was predisposed by chronic hypoxia and was caused by the main genotypes of S. agalactiae and Fno reported in Brazil. Finally, a new S. agalactiae genotype with glcK gene partially deleted was described.

Transferência passiva de soro hiperimune anti-Streptococcus agalactiae e seu efeito profilático em tilápias-do-nilo infectadas experimentalmente: sobrevivência e títulos de anticorpos / Passive transfer of hyperimmune serum anti Streptococcus agalactiae and its prophylactic effect on Nile tilapia experimentally infected

A bactéria Streptococcus agalactiae é um potente agente causador de surtos por doenças bacterianas em peixes. O estresse provocado pelo manejo zootécnico e pela má qualidade ambiental torna a tilápia susceptível às infecções por essa bactéria. O objetivo do presente trabalho foi avaliar a resistência de tilápias-do-nilo imunizadas com soro hiperimune anti-S. agalactiae, posteriormente desafiadas com cepa homóloga da mesma bactéria. Após determinação da DL 50 de S. agalactiae, 36 tilápias foram distribuídas em quatro aquários, dois para o grupo controle e dois para inoculação celomática para produção de anticorpos anti-S. agalactiae. No 21° e 28° dias, foi coletado sangue para obtenção de soro hiperimune utilizado na transferência passiva. Em seguida, 30 tilápias foram distribuídas em três aquários e submetidas a três tratamentos: GI: controle; GII: imunizadas com o soro inativado; GIII: imunizadas com soro ativo. Após 48 horas e sete, 14, 21, 28 e 35 dias, foram realizadas coletas de sangue para titulação de anticorpos anti-S. agalactiae utilizando-se o teste de aglutinação direta. Para avaliar a taxa de sobrevivência, outras 30 tilápias foram distribuídas em três aquários e submetidas a três tratamentos (GI: controle; GII: imunizadas com soro inativado; GIII: imunizadas com soro ativo). Após 48 horas da imunização, as tilápias foram desafiadas via celomática com 100µL de S. agalactiae e avaliadas duas vezes ao dia, pelo período de 35 dias. Os resultados dos títulos séricos de anticorpos foram detectados pela aglutinação direta até o 21° dia pós-transferência passiva, e, no mesmo período, houve proteção de 80% entre os grupos imunizados com soro inativado e soro ativo contendo anticorpos anti-S. agalactiae. Ao final, os grupos soro inativado e soro ativo apresentaram 60 e 80% de proteção, respectivamente, enquanto no grupo controle 100% dos peixes adoeceram, apresentando sinais graves da infecção, e foram eutanasiados. Não houve diferença estatística significativa na taxa de proteção entre os grupos imunizados.(AU)

The Streptococcus agalactiae bacteria is a potent agent which causes outbreaks of bacterial diseases in fish. The stress caused by management and poor environmental quality makes tilapia susceptible to infections, including by bacterium. The aim of this study was to evaluate the resistance of the Nile tilapia immunized with hyperimmune serum against S. agalactiae subsequently challenged with homologous strain of the same bacteria. After determining the DL 50 of S. agalactiae, 36 tilapias were distributed in 4 aquariums, 2 for the control group and 2 for the group via coelomic, inoculated with the DL 50 for anti-S. agalactiae antibodies production. On the 21st and 28th day blood was collected for the obtainment of hiperimmune serum used in passive transference. Then, 30 tilapias were distributed in 3 aquariums submitted to 3 treatments (GI: control; GII: immunized with inactivated-serum; GIII: immunized with non-inactivated serum). After 48 hours, 7, 14, 21, 28 and 35 days blood collections were done for anti-S. agalactiae antibodies titration using the direct agglutination test. For survival evaluation 30 tilapias were distributed in 3 aquariums and submitted to 3 treatments (GI: control; GII: immunized with inactivated-serum; GIII: immunized with non-inactivated serum). After 48 hours of inoculation tilapias were challenged with 100µL of S. agalactiae and monitored twice a day for 35 days. The results showed that titers of antibodies were detected by direct agglutination until the 21st day after passive transference and during the same period the protection between the groups immunized with inactivated serum and non-inactivated serum contending anti-S. agalactiae antibodies was of 80% after challenge with S. agalactiae. In the end, the serum-inactivated serum and active groups had 60 and 80% protection, respectively, while 100% of the fish in the control group developed severe signs of infection and were euthanized. There was no statistical difference in the survival rate between the immunized groups.(AU)

Transferência passiva de soro hiperimune anti-Streptococcus agalactiae e seu efeito profilático em tilápias-do-nilo infectadas experimentalmente: sobrevivência e títulos de anticorpos / Passive transfer of hyperimmune serum anti Streptococcus agalactiae and its prophylactic effect on Nile tilapia experimentally infected

A bactéria Streptococcus agalactiae é um potente agente causador de surtos por doenças bacterianas em peixes. O estresse provocado pelo manejo zootécnico e pela má qualidade ambiental torna a tilápia susceptível às infecções por essa bactéria. O objetivo do presente trabalho foi avaliar a resistência de tilápias-do-nilo imunizadas com soro hiperimune anti-S. agalactiae, posteriormente desafiadas com cepa homóloga da mesma bactéria. Após determinação da DL 50 de S. agalactiae, 36 tilápias foram distribuídas em quatro aquários, dois para o grupo controle e dois para inoculação celomática para produção de anticorpos anti-S. agalactiae. No 21° e 28° dias, foi coletado sangue para obtenção de soro hiperimune utilizado na transferência passiva. Em seguida, 30 tilápias foram distribuídas em três aquários e submetidas a três tratamentos: GI: controle; GII: imunizadas com o soro inativado; GIII: imunizadas com soro ativo...

The Streptococcus agalactiae bacteria is a potent agent which causes outbreaks of bacterial diseases in fish. The stress caused by management and poor environmental quality makes tilapia susceptible to infections, including by bacterium. The aim of this study was to evaluate the resistance of the Nile tilapia immunized with hyperimmune serum against S. agalactiae subsequently challenged with homologous strain of the same bacteria. After determining the DL 50 of S. agalactiae, 36 tilapias were distributed in 4 aquariums, 2 for the control group and 2 for the group via coelomic, inoculated with the DL 50 for anti-S. agalactiae antibodies production. On the 21st and 28th day blood was collected for the obtainment of hiperimmune serum used in passive transference. Then, 30 tilapias were distributed in 3 aquariums submitted to 3 treatments (GI: control; GII: immunized with inactivated-serum; GIII: immunized with non-inactivated serum)...

Validation of absolute quantitative real-time PCR for the diagnosis of Streptococcus agalactiae in fish.

Streptococcus agalactiae (GBS) are Gram-positive cocci responsible for substantial losses in tilapia fish farms in Brazil and worldwide. It causes septicemia, meningoencephalitis and mortality of whole shoals that can occur within 72 h. Thus, diagnostic methods are needed that are rapid, specific and sensitive. In this study, a pair of specific primers for GBS was generated based on the cfb gene sequence and initially evaluated by conventional PCR. The protocols for absolute quantitative real-time PCR (qPCR) were then adapted to validate the technique for the identification and quantification of GBS isolated by real-time detection of amplicons using fluorescence measurements. Finally, an infectivity test was conducted in tilapia infected with GBS strains. Total DNA from the host brain was subjected to the same technique, and the strains were re-isolated to validate Koch's postulates. The assay showed 100% specificity for the other bacterial species evaluated and a sensitivity of 367 gene copies per 20 mg of brain tissue within 4 h, making this test a valuable tool for health monitoring programs.